Sanbo Hospital Management (301293)
Search documents
三博脑科股价异动受多重因素影响
Jing Ji Guan Cha Wang· 2026-02-14 01:50
2026年开年以来,脑机接口成为市场热点。受Neuralink宣布将于2026年启动设备量产以及国内政策将脑 机接口列为未来产业等消息影响,脑机接口概念股受到资金追捧。三博脑科因其神经专科背景及参与全 球首例介入式脑机接口临床试验,被市场视为核心标的。其在1月5日至8日期间股价累计涨幅一度接近 60%,但随后公司发布公告澄清,目前脑机接口业务仍处于实验性阶段,不会对当前业绩产生较大影 响。概念炒作后股价出现回调,截至2月13日收盘报79.68元,较1月高点回调明显。 公司基本面 经济观察网根据公开信息,三博脑科(301293)(301293.SZ)近期的股价异动主要与脑机接口概念炒 作、公司基本面状况以及重大事件进展等多重因素相关。 股价异动原因 近期事件 2026年2月9日盘后,公司公告董事长张阳被相关部门解除责令候查措施,恢复正常履职。该事件自2025 年4月披露以来持续对市场情绪构成压制,此次解除有助于缓解投资者对公司治理稳定性的担忧。公告 次日(2月10日)股价企稳,并在2月13日主力资金净流入1.75亿元,推动单日上涨4.08%。 资金面情况 根据2025年三季报,公司营业总收入12.73亿元,同比 ...
2025年中国脑机接口行业研发现状分析 企业研发投入呈增长趋势【组图】
Qian Zhan Wang· 2026-02-10 05:12
Group 1 - The core viewpoint of the article highlights the increasing investment and research activity in the brain-computer interface (BCI) industry in China, with a focus on key companies and patent trends [1][4][5] Group 2 - The research and development investment in the BCI industry by listed companies in China is steadily increasing from 2020 to 2024, indicating a strengthening of R&D efforts [1] - The number of patent applications in China's BCI industry showed a steady growth trend, peaking at 258 applications in 2021, followed by a decrease to 209 applications in 2024 [4] - Tianjin University is identified as the leading patent applicant in the BCI sector, with a total of 126 related patents, followed by South China University of Technology and Xi'an Jiaotong University with 80 and 78 patents respectively [5][7] - The most popular technology patents in the BCI industry are in the category of electrical digital data processing (G06F), with a total of 1,013 patents, followed by diagnostic and surgical technologies (A61B) with 712 patents, and specific computing models (G06N) with 313 patents [8]
今日晚间重要公告抢先看——金徽股份:拟2.1亿元收购福圣矿业100%股权;盟固利:拟9.29亿元投建年产3万吨锂离子电池正极材料项目
Jin Rong Jie· 2026-02-09 13:25
Group 1 - Jinwei Co., Ltd. plans to acquire 100% equity of Fusheng Mining for 210 million yuan, which will become a wholly-owned subsidiary and included in the consolidated financial statements [2] - Mengguli intends to invest 929 million yuan to build a project with an annual production capacity of 30,000 tons of lithium-ion battery cathode materials, expected to produce 5,000 tons of high-voltage cobalt acid lithium, 10,000 tons of NCA materials, and 15,000 tons of ultra-high nickel ternary materials [2] - Xiamen Tungsten plans to acquire 39% equity of Jiujiang Dadi Mining, which will help increase mineral resource reserves and improve raw material self-sufficiency [3] Group 2 - Andavil's subsidiary received EASA certification for its aviation kitchen plug-in products, marking compliance with European aviation safety standards [2] - CIMC Vehicles disclosed that the US ITC made a preliminary ruling on anti-subsidy and anti-dumping investigations regarding Van-Type Trailers, indicating potential damage to the US domestic industry [4] - Source Technology plans to invest approximately 1.251 billion yuan to build a second phase project for the R&D and production of optoelectronic communication semiconductor chips and devices [9] Group 3 - Zhongmin Energy intends to acquire 51% equity of Mintou Pumped Storage for 864 million yuan, with the transaction price based on asset evaluation [10] - Ningbo Yunsheng plans to publicly issue H-shares and apply for listing on the Hong Kong Stock Exchange [11] - Wenkai Co., Ltd. won a bid for a landscape project worth 50.8162 million yuan [12] Group 4 - China Merchants Shekou achieved a signed sales amount of 7.674 billion yuan in January 2026 [16] - AVIC Optoelectronics reported a net profit of 2.124 billion yuan for 2025, a year-on-year decrease of 36.69% [17] - Tiankang Bio reported a sales revenue of 392 million yuan from pig sales in January 2026, with a month-on-month increase of 6.23% [18] Group 5 - Poly Developments reported a signed amount of 15.617 billion yuan in January 2026, a year-on-year decrease of 13.31% [19] - Chengtou Holdings reported a net profit of 290 million yuan for 2025, a year-on-year increase of 19.67% [20] - Qianjin Pharmaceutical reported a net profit of 288 million yuan for 2025, a year-on-year increase of 24.74% [21]
三博脑科控股股东、实际控制人之一暨董事长张阳解除责令候查
Bei Jing Shang Bao· 2026-02-09 12:25
三博脑科表示,目前,公司正常经营,张阳正常履职。 北京商报讯(记者 丁宁)2月9日晚间,三博脑科(301293)发布公告称,公司于2月8日收到内蒙古自 治区监察委员会签发的《解除责令候查通知书》,相关部门已解除对公司控股股东、实际控制人之一暨 董事长张阳的责令候查措施。 ...
三博脑科:公司正常经营 张阳正常履职
Zheng Quan Ri Bao Wang· 2026-02-09 12:12
证券日报网讯2月9日,三博脑科(301293)发布公告称,公司于2026年2月8日收到内蒙古自治区监察委 员会签发的《解除责令候查通知书》,相关部门已解除对张阳先生的责令候查措施。目前,公司正常经 营,张阳先生正常履职。 ...
2月9日中证医疗(399989)指数涨0.6%,成份股三博脑科(301293)领涨
Sou Hu Cai Jing· 2026-02-09 10:30
Core Viewpoint - The China Securities Medical Index (399989) closed at 7161.62 points, up 0.6%, with a trading volume of 19.192 billion yuan and a turnover rate of 1.97% on February 9 [1] Group 1: Index Performance - On the same day, 37 of the index's constituent stocks rose, with Sanbo Brain Science leading with a 5.32% increase, while 12 stocks declined, with Aier Eye Hospital falling by 2.98% [1] - The top ten constituent stocks of the China Securities Medical Index are primarily in the pharmaceutical and medical sectors, with WuXi AppTec holding the highest weight at 10.03% [1] Group 2: Stock Details - The top ten stocks include: - WuXi AppTec: Weight 10.03%, Latest Price 98.70, Market Cap 294.97 billion yuan [1] - Mindray Medical: Weight 9.12%, Latest Price 189.17, Market Cap 229.36 billion yuan [1] - United Imaging Healthcare: Weight 7.49%, Latest Price 128.92, Market Cap 106.25 billion yuan [1] - Aier Medical: Weight 6.04%, Latest Price 10.74, Market Cap 100.16 billion yuan [1] - Other notable stocks include Tigermed, Kanglong Chemical, and Yuyue Medical, all within the medical and pharmaceutical industry [1] Group 3: Capital Flow - The net outflow of main funds from the index's constituent stocks totaled 205 million yuan, while retail investors saw a net inflow of 1.51 billion yuan [1] - Detailed capital flow indicates that major stocks like WuXi AppTec and Mindray Medical experienced varying levels of net inflow and outflow from different investor categories [2]
2.9犀牛财经晚报:交易所宣布优化再融资一揽子措施
Xi Niu Cai Jing· 2026-02-09 10:26
Group 1: Financing Measures and Market Reactions - The Shanghai and Shenzhen Stock Exchanges announced a package of measures to optimize refinancing, aiming to support high-quality listed companies and improve refinancing efficiency [1] - The domestic gold jewelry prices have rebounded, with prices reaching 1555-1560 RMB per gram [1] - The lithium carbonate market saw a rebound with prices increasing by over 5% due to improved market sentiment [1] Group 2: Price Adjustments and Market Trends - Major global PC manufacturers, including Lenovo and HP, have initiated price increases due to rising upstream storage costs, with some products seeing price hikes of over 600 RMB in a single day [2] - The storage industry is projected to see significant growth, with its value expected to reach 551.6 billion USD, surpassing that of the wafer foundry sector [2] Group 3: Corporate Developments - The company Dingxin Communications faced penalties for short-term trading by its executive, resulting in a fine of 120,000 RMB [7] - Sanbo Brain Science announced the lifting of a supervisory order against its chairman, allowing normal operations to resume [8] - Jinwei Co. plans to acquire 100% of Fusheng Mining for 210 million RMB, expanding its mining operations [10] Group 4: Project Wins and Acquisitions - Yitong Century won a bid for a project worth 107 million RMB to provide comprehensive maintenance services for China Tower [11] - Jida Communication is expected to receive approximately 51 million RMB from a project with China Mobile [12] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for 864 million RMB [13] Group 5: Financial Performance - Qianjin Pharmaceutical reported a slight revenue increase of 0.13% for 2025, with a net profit growth of 24.74% [17] - Dongwei Technology achieved a significant net profit growth of 86.81% for 2025, with total revenue increasing by 47.65% [18] Group 6: Market Performance - The market saw a strong performance with the ChiNext Index rising nearly 3%, driven by AI applications and other sectors [20]
2月9日晚间重要公告一览
Xi Niu Cai Jing· 2026-02-09 10:13
Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]
三博脑科董事长张阳解除责令候查
Zhi Tong Cai Jing· 2026-02-09 09:59
三博脑科(301293)(301293.SZ)发布公告,公司于2026年2月8日收到内蒙古自治区监察委员会签发的 《解除责令候查通知书》,相关部门已解除对张阳先生的责令候查措施。目前,公司正常经营,张阳先 生正常履职。 ...
三博脑科(301293.SZ)董事长张阳解除责令候查
智通财经网· 2026-02-09 09:56
智通财经APP讯,三博脑科(301293.SZ)发布公告,公司于2026年2月8日收到内蒙古自治区监察委员会签 发的《解除责令候查通知书》,相关部门已解除对张阳先生的责令候查措施。目前,公司正常经营,张 阳先生正常履职。 ...